The tardigrade protein that could make cancer patients more resistant to radiation

Tardigrades, known as the most resilient living organisms on the planet, have fascinated scientists with their ability to survive in extreme conditions, from the vacuum of space to lethal radiation. Now, a team of researchers has isolated a key protein from these microorganisms and converted it into messenger RNA, hoping that it may one day protect cancer patients from the devastating effects of radiation therapy.

What makes tardigrades special?

These tiny organisms can withstand extreme temperatures, dehydration, and levels of radiation that would kill any other living thing. Their secret lies in a unique protein that protects their DNA from damage.

How does it work in humans?

Scientists successfully synthesized the protein in messenger RNA form, the same mechanism used in mRNA vaccines against COVID-19. By introducing this protein into human cells in the laboratory, they observed that the cells were much more resistant to radiation.

A promising advance in the fight against cancer

Although still in the experimental phase, this discovery could revolutionize the way radiotherapy is administered, allowing higher doses without damaging healthy tissue and improving the success rate of cancer treatments.

In the future, this protein could be used in space medicine, protecting astronauts from cosmic radiation during extended missions.